USPTO trademark

IMMUNOMODULATORY ALPHA NEUTROPHIL (IMAN)

RegisteredUSPTOWord markClass 1Class 5Class 42

"IMMUNOMODULATORY ALPHA NEUTROPHIL (IMAN)" is a word mark owned by LIfT BioSciences Limited, filed at the USPTO on July 21, 2023. It is registered and covers classes 1, 5 and 42.

Get this data via the API

Data current as of April 22, 2025Official USPTO record

As filed with the USPTO

Status: Registered; Since April 22, 2025
Filed: July 21, 2023
Registered: April 22, 2025
Expires: Not recorded
Application no.: 98095871
Registration no.: 7765108
Office: USPTO; United States Patent and Trademark Office
Mark type: Word mark; 3 classes

Ownership

Who owns IMMUNOMODULATORY ALPHA NEUTROPHIL (IMAN)

The owner and representative on file with the office.

Owner

LIfT BioSciences Limited

London, United Kingdom

Representative

Steven E. Lauridsen

Tucker Ellis LLP

Goods and services

What the mark covers

The products and services IMMUNOMODULATORY ALPHA NEUTROPHIL (IMAN) is filed for, grouped by Nice class.

01Class 1 · Chemicals
Chemicals for use in biotechnological manufacturing processes; Chemicals for use in biotechnological product development; Chemical substances for use in the biotechnological industry; media for cell culture for research use in the biotechnological industry; Chemical reagents for use in biotechnology, other than for medical or veterinary use; all of the aforesaid being for use in cell therapy, living cell therapy and the treatment of cancer
05Class 5 · Pharmaceuticals
Biotechnological immune cell preparations for medical use; all of the aforesaid being for use in cell therapy, living cell therapy and the treatment of cancer
42Class 42 · Computer and Scientific Services
Biotechnological research; Biotechnology research; Research relating to biotechnology; Biotechnological research relating to industry; Research and development in the field of biotechnology; Research and development in the pharmaceutical and biotechnology fields; Information on the subject of scientific research in the field of biochemistry and biotechnology; all of the aforesaid relating to cell therapy, living cell therapy and the treatment of cancer

History

What has happened so far

Steps recorded by the USPTO, newest first.

April 22, 2025Notice of registration confirmation emailed
April 22, 2025Registered-principal register
March 4, 2025Published for opposition
March 4, 2025Official gazette publication confirmation e-mailed
February 26, 2025Notification of notice of publication e-mailed
February 6, 2025Approved for pub - principal register
February 5, 2025Teas/email correspondence entered
February 5, 2025Correspondence received in law office
February 5, 2025Teas request for reconsideration received
February 3, 2025Notification of final refusal emailed

10 earlier steps on the official record.

FAQ

About IMMUNOMODULATORY ALPHA NEUTROPHIL (IMAN)

Who owns the trademark "IMMUNOMODULATORY ALPHA NEUTROPHIL (IMAN)"?

The USPTO trademark "IMMUNOMODULATORY ALPHA NEUTROPHIL (IMAN)" (application 98095871) is owned by LIfT BioSciences Limited.

What is the status of "IMMUNOMODULATORY ALPHA NEUTROPHIL (IMAN)"?

Its status at the USPTO is: registered.

When was "IMMUNOMODULATORY ALPHA NEUTROPHIL (IMAN)" registered?

It was registered on April 22, 2025.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull IMMUNOMODULATORY ALPHA NEUTROPHIL (IMAN) and marks like it into your own product with one request.

GET/v1/trademarks/{id}
The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/events
Every step in the office history
GET/v1/proceedings?trademark_id={id}
Oppositions and cancellations against the mark

Get API key View docs

GET /v1/trademarks/{id}

ID=tm_019d2bec-79f0-77af-bf7f-e0c2311bb8ce
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"

Response

{
  "id": "tm_019d2bec-79f0-77af-bf7f-e0c2311bb8ce",
  "object": "trademark",
  "mark_text": "IMMUNOMODULATORY ALPHA NEUTROPHIL (IMAN)",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "US",
  "application_number": "98095871",
  "filing_date": "2023-07-21",
  "nice_classes": [
    1,
    5,
    42
  ],
  "owners": [
    {
      "name": "LIfT BioSciences Limited",
      "entity_id": null
    }
  ]
}